|
|
Volumn 36, Issue 8, 2004, Pages 2311-2312
|
|
Prevention of de novo hepatitis B infection from HbcAb-positive donors in living donor liver transplantation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HEPATITIS B ANTIBODY;
HEPATITIS B CORE ANTIBODY;
HEPATITIS B VACCINE;
LAMIVUDINE;
ANTIBODY TITER;
CAUSE OF DEATH;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SCREENING;
FEMALE;
GRAFT INFECTION;
HEPATITIS B;
HUMAN;
INFECTION PREVENTION;
LIVER GRAFT;
LIVER TRANSPLANTATION;
LIVING DONOR;
MALE;
MONOTHERAPY;
ORGAN DONOR;
PRIORITY JOURNAL;
RECIPIENT;
SIDE EFFECT;
VACCINATION;
CHILD;
HEPATITIS B;
HEPATITIS B CORE ANTIGENS;
HEPATITIS B VACCINES;
HUMANS;
LIVER TRANSPLANTATION;
LIVING DONORS;
POSTOPERATIVE COMPLICATIONS;
|
|
EID: 9244237030
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.08.139 Document Type: Conference Paper |
|
Times cited : (33)
|
|
References (4)
|
